Detection of telomerase activity in exfoliated cancer cells obtained from bile.

T. Itoi, K. Ohyashiki, N. Yahata, Y. Shinohara, K. Takei, K. Takeda, K. Nagao, H. Hisatomi, Y. Ebihara, J. W. Shay, T. Saito

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Telomerase is detected by the telomeric repeat amplification protocol (TRAP) assay in more than 85% of primary cancers. In the present study, we determined telomerase activity using exfoliated bile cells obtained from biliary tract neoplasia specimens. The aim of this study was to provide additional information regarding minimally invasive approaches to the detection of biliary tract cancer in combination with routine cytologic examination. We analyzed for telomerase activity bile juice from patients with gallbladder carcinoma, cholangiocarcinoma, cholecystitis and cholangitis. Semiquantitative determination of telomerase activity was performed using both a fluorescence-based TRAP assay on cell extracts and at the cellular level by an in situ TRAP assay. The fluorescence-based TRAP assay detected bile telomerase activity in samples from 4 of 10 patients with biliary tract cancer. In contrast, the in situ TRAP assay detected telomerase positive cells in samples from 6 of 10 patients with biliary tract cancer. However, only one of these samples showed class V cytology. A combination of semiquantitative analysis and an in situ TRAP assay to detect telomerase positive cells may improve the diagnosis of biliary tract cancers with the combination of routine cytologic examination.

Original languageEnglish (US)
Pages (from-to)1061-1067
Number of pages7
JournalInternational Journal of Oncology
Volume15
Issue number6
StatePublished - Dec 1999

Fingerprint

Telomerase
Bile
Biliary Tract Neoplasms
Neoplasms
Fluorescence
Cholecystitis
Cholangitis
Cholangiocarcinoma
Biliary Tract
Gallbladder
Cell Extracts
Cell Biology
Carcinoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Itoi, T., Ohyashiki, K., Yahata, N., Shinohara, Y., Takei, K., Takeda, K., ... Saito, T. (1999). Detection of telomerase activity in exfoliated cancer cells obtained from bile. International Journal of Oncology, 15(6), 1061-1067.

Detection of telomerase activity in exfoliated cancer cells obtained from bile. / Itoi, T.; Ohyashiki, K.; Yahata, N.; Shinohara, Y.; Takei, K.; Takeda, K.; Nagao, K.; Hisatomi, H.; Ebihara, Y.; Shay, J. W.; Saito, T.

In: International Journal of Oncology, Vol. 15, No. 6, 12.1999, p. 1061-1067.

Research output: Contribution to journalArticle

Itoi, T, Ohyashiki, K, Yahata, N, Shinohara, Y, Takei, K, Takeda, K, Nagao, K, Hisatomi, H, Ebihara, Y, Shay, JW & Saito, T 1999, 'Detection of telomerase activity in exfoliated cancer cells obtained from bile.', International Journal of Oncology, vol. 15, no. 6, pp. 1061-1067.
Itoi T, Ohyashiki K, Yahata N, Shinohara Y, Takei K, Takeda K et al. Detection of telomerase activity in exfoliated cancer cells obtained from bile. International Journal of Oncology. 1999 Dec;15(6):1061-1067.
Itoi, T. ; Ohyashiki, K. ; Yahata, N. ; Shinohara, Y. ; Takei, K. ; Takeda, K. ; Nagao, K. ; Hisatomi, H. ; Ebihara, Y. ; Shay, J. W. ; Saito, T. / Detection of telomerase activity in exfoliated cancer cells obtained from bile. In: International Journal of Oncology. 1999 ; Vol. 15, No. 6. pp. 1061-1067.
@article{c5fcf43e2d57426fbe4b6023f68f7c3c,
title = "Detection of telomerase activity in exfoliated cancer cells obtained from bile.",
abstract = "Telomerase is detected by the telomeric repeat amplification protocol (TRAP) assay in more than 85{\%} of primary cancers. In the present study, we determined telomerase activity using exfoliated bile cells obtained from biliary tract neoplasia specimens. The aim of this study was to provide additional information regarding minimally invasive approaches to the detection of biliary tract cancer in combination with routine cytologic examination. We analyzed for telomerase activity bile juice from patients with gallbladder carcinoma, cholangiocarcinoma, cholecystitis and cholangitis. Semiquantitative determination of telomerase activity was performed using both a fluorescence-based TRAP assay on cell extracts and at the cellular level by an in situ TRAP assay. The fluorescence-based TRAP assay detected bile telomerase activity in samples from 4 of 10 patients with biliary tract cancer. In contrast, the in situ TRAP assay detected telomerase positive cells in samples from 6 of 10 patients with biliary tract cancer. However, only one of these samples showed class V cytology. A combination of semiquantitative analysis and an in situ TRAP assay to detect telomerase positive cells may improve the diagnosis of biliary tract cancers with the combination of routine cytologic examination.",
author = "T. Itoi and K. Ohyashiki and N. Yahata and Y. Shinohara and K. Takei and K. Takeda and K. Nagao and H. Hisatomi and Y. Ebihara and Shay, {J. W.} and T. Saito",
year = "1999",
month = "12",
language = "English (US)",
volume = "15",
pages = "1061--1067",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "6",

}

TY - JOUR

T1 - Detection of telomerase activity in exfoliated cancer cells obtained from bile.

AU - Itoi, T.

AU - Ohyashiki, K.

AU - Yahata, N.

AU - Shinohara, Y.

AU - Takei, K.

AU - Takeda, K.

AU - Nagao, K.

AU - Hisatomi, H.

AU - Ebihara, Y.

AU - Shay, J. W.

AU - Saito, T.

PY - 1999/12

Y1 - 1999/12

N2 - Telomerase is detected by the telomeric repeat amplification protocol (TRAP) assay in more than 85% of primary cancers. In the present study, we determined telomerase activity using exfoliated bile cells obtained from biliary tract neoplasia specimens. The aim of this study was to provide additional information regarding minimally invasive approaches to the detection of biliary tract cancer in combination with routine cytologic examination. We analyzed for telomerase activity bile juice from patients with gallbladder carcinoma, cholangiocarcinoma, cholecystitis and cholangitis. Semiquantitative determination of telomerase activity was performed using both a fluorescence-based TRAP assay on cell extracts and at the cellular level by an in situ TRAP assay. The fluorescence-based TRAP assay detected bile telomerase activity in samples from 4 of 10 patients with biliary tract cancer. In contrast, the in situ TRAP assay detected telomerase positive cells in samples from 6 of 10 patients with biliary tract cancer. However, only one of these samples showed class V cytology. A combination of semiquantitative analysis and an in situ TRAP assay to detect telomerase positive cells may improve the diagnosis of biliary tract cancers with the combination of routine cytologic examination.

AB - Telomerase is detected by the telomeric repeat amplification protocol (TRAP) assay in more than 85% of primary cancers. In the present study, we determined telomerase activity using exfoliated bile cells obtained from biliary tract neoplasia specimens. The aim of this study was to provide additional information regarding minimally invasive approaches to the detection of biliary tract cancer in combination with routine cytologic examination. We analyzed for telomerase activity bile juice from patients with gallbladder carcinoma, cholangiocarcinoma, cholecystitis and cholangitis. Semiquantitative determination of telomerase activity was performed using both a fluorescence-based TRAP assay on cell extracts and at the cellular level by an in situ TRAP assay. The fluorescence-based TRAP assay detected bile telomerase activity in samples from 4 of 10 patients with biliary tract cancer. In contrast, the in situ TRAP assay detected telomerase positive cells in samples from 6 of 10 patients with biliary tract cancer. However, only one of these samples showed class V cytology. A combination of semiquantitative analysis and an in situ TRAP assay to detect telomerase positive cells may improve the diagnosis of biliary tract cancers with the combination of routine cytologic examination.

UR - http://www.scopus.com/inward/record.url?scp=18744427236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18744427236&partnerID=8YFLogxK

M3 - Article

C2 - 10568809

AN - SCOPUS:18744427236

VL - 15

SP - 1061

EP - 1067

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 6

ER -